CD44

You have access
CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal Metastasis After Surgery
ANDREAS MICHAEL SIHOMBING, SATOSHI MURATA, MIYUKI SHIMOJI, TORU MIYAKE, KATSUSHI TAKEBAYASHI, HIROKAZU KODAMA, AYA TOKUDA, MASATSUGU KOJIMA, TOMOYUKI UEKI, NAOMI KITAMURA, MINA KITAMURA, EIJI MEKATA and MASAJI TANI

Anticancer Research June 2023, 43 (6) 2491-2500; DOI: https://doi.org/10.21873/anticanres.16416
You have access
SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
PIOTR CIERPIKOWSKI, ANNA LIS-NAWARA and JULIA BAR

Anticancer Research November 2021, 41 (11) 5405-5413; DOI: https://doi.org/10.21873/anticanres.15352
You have access
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE and JUN TEISHIMA

Anticancer Research October 2021, 41 (10) 4875-4883; DOI: https://doi.org/10.21873/anticanres.15301
You have access
Distribution and Expression of the Adhesion Molecule CD44 on Human Corneal Grafts Is Not Altered by Chemotherapy
GEORGIOS S. DIMTSAS, XANTHIPPI GRAMMATOGLOU, THEODOSIA CHOREFTAKI, MARIA DETTORAKI, AIKATERI KARATHANOU, NIKOLAOS GOULIOPOULOS, CHRISTOS DAMASKOS and MARILITA M. MOSCHOS

Anticancer Research December 2020, 40 (12) 6885-6889; DOI: https://doi.org/10.21873/anticanres.14711
You have access
Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression
SAWAKO MIYOSHI, HITOSHI TSUGAWA, JUNTARO MATSUZAKI, KENRO HIRATA, HIDEKI MORI, HIDEYUKI SAYA, TAKANORI KANAI and HIDEKAZU SUZUKI

Anticancer Research November 2018, 38 (11) 6163-6170; DOI: https://doi.org/10.21873/anticanres.12969
You have access
Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma
HIROKO MATUURA, MORIKAZU MIYAMOTO, MASASHI TAKANO, HIROAKI SOYAMA, TADASHI AOYAMA, TOMOYUKI YOSHIKAWA, KENTO KATO, TAKAHIRO SAKAMOTO, MIKA KUWAHARA, KAZUKI TAKASAKI, HIROKI ISHIBASHI, HIDEKI IWAHASHI, HITOSHI TSUDA and KENICHI FURUYA

Anticancer Research February 2018, 38 (2) 717-722;
You have access
Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma
ANDERS NÄSMAN, CINZIA BERSANI, DAVID LINDQUIST, JUAN DU, TORBJÖRN RAMQVIST and TINA DALIANIS

Anticancer Research October 2017, 37 (10) 5319-5328;
You have access
Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma
TOMOHIKO SAKABE, JUNYA AZUMI, YOSHIHISA UMEKITA, KAN TORIGUCHI, ETSURO HATANO, YASUAKI HIROOKA and GOSHI SHIOTA

Anticancer Research September 2017, 37 (9) 4881-4888;
You have access
Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer
ARNAUD DA CRUZ PAULA and CARLOS LOPES

Anticancer Research May 2017, 37 (5) 2173-2183;
You have access
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients
MICHAEL STOTZ, SEREINA A. HERZOG, MARTIN PICHLER, MARIA SMOLLE, JAKOB RIEDL, CHRISTOPHER ROSSMANN, ANGELIKA BEZAN, HERBERT STÖGER, WILFRIED RENNER, ANDREA BERGHOLD and ARMIN GERGER

Anticancer Research April 2017, 37 (4) 2011-2018;

Main menu

User menu

Search

CD44

Pages